2024 Trends & FLG Partners Celebrates 20 Years of Success
By Laureen DeBuono
In 2024, FLG Partners will celebrate our 20th Anniversary in business, thanks to the hundreds of clients, referral partners and industry colleagues who have helped us meet our objectives. Because of partnering with these colleagues, we have been able to close: 350+ M&A transactions 200+ IPOs 100+ Divestiture transactions And…Read More
Read MoreLatest Insights: 2023 Healthcare, Technology and Consumer Trends
By Laureen DeBuono
FLG Partners’ C-suite consulting and advisory practice supports a diverse continuum of industry sectors, from healthcare and life sciences to technology (SaaS and software to med tech and hardware) and consumer, from e-commerce to CPG. Our partners regularly attend many industry conferences and networking opportunities to stay abreast of the…Read More
Read MoreLooking Back at 2022 and Looking Forward to 2023
By Laureen DeBuono
As we all know, 2022 presented many challenges to each of us, on many fronts. From the ebbing yet persistent pandemic, to business disruptions, the lack of equity capital, the Ukraine war and its impacts on supply chains and global food sources, the “good and bad” of hybrid work formats,…Read More
Read MoreBetter Board Governance in Challenging Times: What Makes the Difference?
By Laureen DeBuono
(with contributing author Jeff Kuhn) Laureen DeBuono is currently Lead Independent Board Director at Rani Therapeutics (NASDAQ: RANI), and Jeff Kuhn is currently Chair of the Audit Committee and on the board at Skyline Enterprises. Both FLG partners have served as past directors and Committee Chairs at a number of…Read More
Read More